After having considered the general definition of biosensors, the specifications of one type are discussed here in more detail, namely the pH-sensitive ISFET, which is at present being clinically investigated for intravascular blood pH recording . Results, advantages and possible improvements will be discussed, as well as a prediction with respect to future developments of FE?-based biosensors .
1 6 P. Bergveld this journal do not de ne in their editorial introduction precisely whicl field they will cover (Biosensors, 1 (1) (1985) ) . They propose a rather broad field involving the interfaces between biology, chemistry an( physics in order to improve medical diagnosis as well as the control o biotechnological processes .
Irk other recent papers the biosensor concept is limited to the inter facing between biochemistry and micro-electronics, in such a way that i will enable biochemical and chemical analyses to be done on a microscalt suitable for in situ measurements . A proposal which goes one step furthe is the development of biochips, where micro-electronic circuitry nowadays mostly consisting of a silicon chip, has also acquired biochemical nature (Tucker, 1984) .
Personally, the author would like to compare biosensors with ON natural type of biosensors, which are as old as the living organisms or earth, namely the bioreceptors (Stieve, 1983) . Bioreceptors are nature transducers which convert all types of chemical and physical signals from the environment into electrical signals, resulting in action potential which can be processed by the natural computer consisting of nerve a brain tissue . Note that the presence of bioreceptors is not limited to oil organs of sense but that they appear in widely varying locations fix 0 1 kinds of physical, chemical and biochemical processes it living organisms and cells .
Because our industrial computers need electrical signals which art carried by electrons, the artificial bioreceptors we are at presen developing will in addition have to contain a conversion to an electrons 1 . This conversion can be direct or indirect . Examples of a direc conversion are the potentiometric and arnperometric mode of sensa operation, while the use of an intermediate optical signal line is ar example of an indirect conversion . The use of a direct or indirect signal conversion depends mainly on thi p esence of observed sensing effects or is imposed by external condition as, for instance, safety requirements . Nevertheless, if biosensors art defined as analogues of bioreceptors, it will be clear that the technolog by which these sensors are produced is of minor importance . In principle every effect which can be made useful for a desired signal conversion is, suitable_ choice for application in biosensor development . It is known g systems and non-living materia very difficult to achieve, especially if the conditions are not wel established . This means that the development of bibsensors has been sought in the use of an intermediate layer, the operational conditions of which can be controlled and stabilized in such a way that contact with both sides fulfils the corresponding requirements . One side should be biocompatible with the living surroundings, while the other side should be compatible with the attached sensor . This situation is shown schematically in Fig . 1 .
Let us consider, as an example, the use of a catheter tip blood pressure sensor . The sensor itself always consists of a membrane, the displacement of which is converted into an electrical signal . To make the sensor suitable for bioappli .cations the membrane has to be covered by a biocompatible layer which prevents thrombogenic reactions but ,does not influence the characteristics of the pressure sensor . It should form a very good attachment to the sensor membrane but should not change its mechanical properties .
An example from the chemical sensing field is an enzymatically controlled sensor for measuring a certain substrate S . An enzymatic reaction converts the substrate S into a product P which can be measured by a P sensor . These reactions are mostly influenced by the chemical Note that the first example described above (the blood pressure sensor) is designed for in vivo measurements . The living organism mentioned in Fig . 1 is in this case the blood inside a human body . The second example (the enzyme sensor) is not necessarily limited to the field of medical care . In this case the living organism and the intermediate layer in Fig . I can be integrated, e .g. enzymes or cells which are immobilized in a polymeric matrix . The application could be useful in biotechnology and other fields .
The use of an intermediate layer which contains biologically active material is the reason that some authors denote these sensors as biosensors, but it will be clear that it limits the definition of a biosensor as an artificial bioreceptor and does not include the sensors for measuring biophysical parameters such as blood pressure, blood flow, etc . Because these sensors can be distinguished from their industrial counter parts precisely by the biomedical application with its specific requirements, the author prefers to include them in the definition of biosensors ; this is in complete agreement with the comprehension of bioreceptors .
With respect to the medical application of these biosensors it will be clear that in the first place they will be used for diagnostic purposes, especially if measurements by means of a sampling technique and off-line analysis show an unallowable deficiency and therefore a continuous online measurement is necessary, e .g. to monitor fast transients of important parameters . A further application will be the use of implantable sensors for controlling, for instance, the functioning of artificial organs such as a pacemaker or an insulin delivery system . It will be clear that the requirements for biocompatibility, accuracy, stability, reliability, etc ., will be much greater for implantable sensors than for monitoring sensors . The latter can be of a disposable type .
A sensor concept which is strongly favoured for the development of these . biosensors is the ion-sensitive field effect transistor (ISFET) (Bergveld && de Rooij, 1981) . This device is based on a direct conversion of the concentration of chemical species into an electronic signal . The measurement does not influence the chemical composition of the intermediate layer (Fig . 1 ) due to its capacitive nature .
.To date the ISFET has been -mainly developed for pH measurements a and ap but research efforts are progressing and other ions and molecules will certainly be measurable by means of modified ISFETs in the near future .
Because of these high expectations it will be useful to first explain t basic operation of the device, then show the present state of clinical applications, including a discussion of the measurement results, and finally discuss the problems which still have to be solved . Based on this knowledge we can consider further the future possibilities of FE: I -based biosensors .
. THE IShET OPERATION
A very short description of the operation of an ISI-ET can be ma e by comparing it with its purely electronic analogue, the MOSFET (metal oxide semiconductor field effect transistor) (Bergveld & de Rooij, 1981) . ( 1) in which /3 is a parameter, determined by the mobility of the electrons in the inversion layer, the gate insulator capacitance per unit area C ., and the width to length ratio of the channel WI L .
Besides differences in the performance of the two devices, there is a difference in the value of the threshold voltage V T, which is constant in the case of a MOSFET but is a function of the pH of the liquid for the ISFET, according to eqns (3) and (4) Therefore this parameter has to be investigated in more detail (Bousse et al ., 1983) .
. THE SITE-DISSOCIATION MODEL
The theory which describes the interaction between an inorganic insulator and an adjacent electrolyte is based on the assumption that the The resulting surface potential, qjo, can be calculated from the total number of surface sites, N ., which will be partly charged to a surface the equilibrium e charge, o-() , depending on .
constants K a and K h:~ = 2 .3 k~t 1 (P -PH) (5) into eqns (4), (3) and (1), respectively, results in a fixed relation between the drain current of an ISFET and the pH of the measuring solution .
. PRACTICAL ISFET APPLICATION
In order to obtain a stable ISFET operation, the ISFET is always applied in a feedback circuit (Bergveld, 1981) . This will always result in an operation mode where the drain-source voltage has a constant preset value and the feedback control also ensures a constant drain current . This will result in a gate-source voltage that is adapted to the value of lp o. As the gate voltage is actually the voltage of the reference electrode, which is usually the ground connection of the feedback amplifier, it means that the source voltage with respect to ground exactly follows the pH-dependent surface potential, *t,, as given in eqn (5) . Figure 4 shows the result of a measurement with an A1 203-ISFET. where Vout is the output voltage of the amplifier, equal to the source voltage with respect to ground and where the amplifier offset control is set to 0 V for pH = 7 . This result shows that an A120 3-ISFET behaves almost linearly in a wide pH-range around its pH,,,. = 7 . 9 with a sensitivity of 53 mV/pH .
For biomedical application the ISFET chips, usually 2 or 3 mm long and 1 or 1 . 5 mm wide, are encapsulated as an integral part of a catheter or hypodermic needle, in order to be able to insert them into a blood vessel or directly into tissue .
The development an applica on of FET-based biosensors .
THE PRESENT STA't E OF IN-VIVO ISFET USE
The Sentron company (Roden, The Netherlands) has developed, especially for use in intravascular measurements, a catheter tip pH ISFET sensor, based on the original work at the Twente University of Technology . This sensor is at present under clinical investigation . The use of A1 20 3 as inorganic gate material is essential, because it combines a rather large pH-sensitivity with excellent biocompatibility . The 6F catheter has a built-in reference electrode of the Margules type (Margules et al ., 1983) and an additional lumen for taking blood samples . Each ISFET is factory-tested in vitro before sterilization, and the essential parameters, which will be dealt with below, are stored in a PROM (programmable read only memory) which is an integral part of the ISFET connector . Experience obtained from animal as well as clinical experiments has shown that the in vitro characterization is also valid for . the in vivo use of the devices . Therefore, the data stored in the PROM . connector also have an in vivo valuation and are used by the floating signal conditioner to transfer the ISFET output signal"to the blood . pH . The signal conditioner applies the ISFET in the constant drain current mode, with constant source-drain voltage, Vd5, resulting in a gate-source voltage, V gs , which directly reflects the pH-sensitive interfacial potential at the gate surface . If no temperature sensitivity and time drift occur, the equation handled by the signal conditioner would be simply : PH = pH ca, + Vgs (6) S where pHca, is the pH of a calibration liquid at 37°C (T.1), V.s the electrical output signal of the ISFET amplifier circuit and S the pH sensitivity (mV/pH) of the particular ISFET, stored in the memory . Although the ISFET is roughly applied at the temperature-insensitive bias point, it appears that a temperature sensitivity of Vgs as well as S still occurs, which has to be corrected . Furthermore it appears that, after an initial drift, the time drift of the A1 20,-ISFET can be approximated to be linear for a certain time . Therefore a linear time drift correction is necessary (de Rooij & Haemmerli, 1984) . This correction (DC in mV/h) as well as the temperature coefficient TC (in mV/°C) and the temperature dependence of S, dS/dT (in mV/pH/°C), are also determined in vitro and stored in the ISFE"I-PROM connector . These data are used for the exact pH deter-. urination by the signal conditioner according to : pH = PHcat + A V9S + DCAt + (TC -S x 0-0147) AT (7) S + WT AT where At is the time after calibration with pH,,,,, and AT is the difference of the temperature with respect to Tca, = 37°C ; in addition a factor S X 0 .0147, which is the same for all ISFETs, is taken into account for correction of the . temperature sensitivity of the blood pH itself .
In order to measure the actual blood temperature necessary to solve eqn (7), the ISFET chip contains a temperature-sensitive resistor, which is also characterized beforehand ; the data from the resistor are also stored in the PROM connector . Equation (7) expresses the essential procedure as developed and patented by Sentron (formerly Cordis) . In this way the present ISFETs can be applied with well-defined accuracy, despite their intrinsic drift phenomenon and temperature dependency . The complete ISFET catheter assembly is shown in Fig . 5 . The ISFETs are protected against electrostatic damage . The sterilized catheters are stored with the ISFET chip in a dry environment, while the tip, containing the reference electrode, is kept in a wet environment .
When making a recording the ISFET and the reference electrode have to be brought into contact with the calibration liquid or with blood for at least half an hour, before the signal conditioner can handle eqn (7) correctly . If the ISFET is in contact with bland during this conditioning period, the calibration is achieved by means of a blood sample, the pH of which has to be determined by pH laboratory equipment .
An actual ISFET registration during spontaneous breathing is shown in g. 6 . The ISFET was calibrated using a blood sample, after an initial conditioning period of halt an hour, with the catheter tip in the, . iliac y . The two dots are blood sample pH values for comparison ISFET recording . The this registratio and from others not given here, that during spontaneous breathing the blood pH may vary by at least 0-06 pH units ; this indicates that the pH determination of an arbitrary blood sample within an accuracy of 0 . 001 pH unit, as is possible with the modern pH-blood gas analysers, is physiologically insignificant .
The real value of a continuous on-line pH measurement will be clear from observation of the registrations in Figs 7(a) and (b) . Again the dots refer to the pH value of blood samples, taken for comparison . Figure 7 (a) shows the result of successful weaning after a period of mechanical ventilation . The patient was put on a pH value of 7-4 and took control of his own acid-base balance after starting weaning from the mechanical ventilation (at I ) within a few minutes at a slightly lower pH value The registration shown in Fig . 7(b) shows an unsuccessful weaning at point a, which is the reason for the anaesthetist deciding to restart the mechanical ventilation at point b .
It will be clear that such a very important and relatively fast phenomenon can hardly be observed with a sampling technique needing further time-consuming off-line analysis and especially not on a routine basis . More details concerning the medical significance of these measurements can be found (Van de Starre et al-, 1986 ) .
In conclusion it can be stated that it is possible to perform on-line continuous pH recording, which makes the ISFET a worthwhile tool It provides the physician with the facility to monitor pH trends, enabling the necessary rapid decisions to be made, and thus improving the clinical treatment of the patient .
. FUTURE DEVELOPMENTS
Now that it is clear that the use of ISFETs is a reality, even under clinical conditions, the question arises as to which improvements have to be implemented to make them a commonly accepted biomedical tool, and which modifications and extensions can be expected in the near future to make them suitable for the measurement of other chemical species .
With respect to desired improvements of the present type of catheter tip pH ISFET, it will be clear that a system with in vivo calibration possibilities would greatly enhance the measurement time, which is now limited to the predictable behaviour time of the ISFET, or in other words . as long as the various parameters stored in the accessory PROM are constant . In particular, it will be clear that in vivo calibration facilities will be an absolute necessity for ISFETs implanted for very long periods .
An approach, at present under investigation at the Twente Universit}' of Technology, is the integration of a micro-coulometric cell with the ISFET chip . This cell contains a working electrode around the ISFEI gate and a counter electrode at a certain distance from the gate, applying a current pulse . A known EspH can now be induced very locally at certain time intervals, resulting in an ISFET response from which the pH sensitivity can be determined . A future development for implantable sensors with on-board calibration facilities is schematically drawn in Fig .  8 . A further improvement of the present ISFET, especially with respect to its production costs, would be its integration with a solid-state reference electrode . Up to now the reference electrodes in use are of the salt-bridge type . An Ag1AgC1 electrode is immersed in a KCl liquid or gel which makes contact with the solution to be measured by means of a porous plug . Production technology of such a device is completely incompatible with the planar ISFET technology . It will be obvious that a completely solid-state reference electrode, made using planar technolog) as an integral part of the sensor chip, would be preferable, but . surprisingly, up to now, at least in the literature, little attention has been paid to this point .
The most promising approach, described in the literature by various authors but not yet put into practice, is the development of a so-called 17, T ( a ara et al., 1982) . A REFET is essentially an ISFET, the a e of which is made insensitive to ions . The REt-aT should be applied, together with an ISFET, in a differential mode, while the common lead of the amplifier is connected to a simple platinum electrode, evaporated on the chip, which also contains the REFET as well as the ISFET . This approach is shown schematically in Fig. 9 .
Although the platinum electrolyte interface is not reversible and thus generates an unstable voltage, this voltage is measured by the differential ISFET/REFET pair as a common mode voltage and will therefore not result in an output voltage . A change in the pH of the liquid will however, be measured as a differential signal between the ISFET and the REFET. suppression of the e mmon mode voltages can only be accomplished if the CMRR of the amplification system is high . A high CMRR can, however, only be achieved if the ISFET and the REFET, have the same sensitivity for electrical potentials . A REFET/ISFET pair consisting essentially of two will, howev r, always have very different electrical sensitivities .
A solution to this problem is not to use an ISFET and a REFET, but electrically equal ISFETs, which differ, however, in their chemical sensitivity . This approach was shown to be valid by Kuisl (Kuisl & Klein, 1982) , who exploited the different chemical sensitivities of a S1 3N 4 and a Si0 2 ISFET . Both ISFETs were applied in a constant drain-current mode . The difference between the output voltages of both signal conditioners only reflected a change in pH and was not sensitive to common mode signals up to 500 mV .
In summary, the ISFET/REI-'ET or dual ISr ET approach will probably be the best solution for the implantable use of ISFETs, because no sail bridge with an inherent low lifetime is necessary .
OTHER FET-BASED BIOSENSORS
The ISFETs realized up to now, and which have been deve aped to the point where they can be actually used in clinical practice as described in Section 5, are all inorganic gate ISI-tTs and thus explicitly sensitive to pH .
ISFETs described in the literature for the measurement of other ions make use of additional membranes which cover the gate area and which are sensitive to other ions (Sibbald, 1983) . In principle, the same membranes as those used for the more conventional solid-state ion .
nsitive electrodes can be applied, such as coated wire electrodes .. ISFETs have the advantage that they also accept insulating materials asc acing, e .g ., photoresist, which may contain specific ion-carrier ligands .
. suffer from a limited li etime . This is mainly caused by the poor attachment of the specific . membranes to the original inorganic gate materials, which consists of 2 physical bond . It would be more convenient to modify the inorganic gate material of the ISFET chemically, in such a way that the hydroxyl group{ P. Bergveld
The development and app ication of FET-based biosensors react with certain groups of the membrane material whose outside surface is sensitive to ions other than W . Such surface modification processes are already known from metal ion chromatography, where crown ethers are chemically bound to silica gel . We have recently started to investigate whether these processes can also be implemented in planar ISFET technology . This is very promising because it is known that a large variety of crown ethers can be synthesized, each type having a very specific affinity for one type of ion . The same concept of chemical surface modification can also be used to develop REt-ETs as mentioned in the previous section .
FET-based sensors are also discussed in the literature on biosensors coated with a bioactive material_ An example is the enzyme FET (Niyahara et al., 1983) . In this case the ISFET is coated with a gel membrane which contains immobilized enzymes . These enzymes control very specific chemical reactions, resulting in chemical products which can be measured by the underlying ISFET .
In this way urea can be measured by cans of the enzyme urease, immobilized in a membrane which covers an ISFET, due to a local pH change resulting from the reaction : (NH2 ) 2CO + 21-1 20 + H ") 2NH
The development of ENFETs is, however, faced with the same problem of membrane fixation as mentioned above with respect to membrane-covered ISFETs . In addition, ENFETs suffer from the same problem as found in the more conventional enzyme sensors, namely the limited lifetime of the immobilized enzymes .
A further example of FET-based biosensors is the Inimuno FET ; of which even less has been announced in the literature -than for ENI-ETs (Schenck, 1978) . The development of an IMFET is based on the knowledge that ISFETs appear to be very.sensitive for any electrical interaction at the surface . It is therefore expected that if it is possible to adsorb or covalently bond a layer of antibodies or antigens to the ISFET surface as with the ELISA technique (enzyme linked immunosorbent assay), reaction with the corresponding antigen or antibody would result in a change of the surface potential of the ISFET and thus in the drain current . However, this effect has still to be proved possible under ' 'c conditions . Improvements are desirable with respect to the character of the reference 'electrode or reference system, as well as to the in vivo calibration possibilities, especially those concerning the implantable application .
All other FET-based biosensors, including the chemically sensitive sensors as well as the biochemical types, are still under investigation . At present they all exist as laboratory prototypes .
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